Latest Webinars, eBooks, & Podcasts

Latest Commentary

Magazine

In this issue of GEN, the cost of sequencing a genome has been coasting down from $1000 and is heading toward $100. The announcement of germline-edited CRISPR twins in China once again highlights the need for regulation into this emerging arena. This month’s A-List covers the Top 25 biotech companies of the past year. And PATH—a new organization promoting the use of AI, robotics, and genomics in healthcare—is profiled.

Recently Featured

Stay Connected

557,677FansLike
45,821FollowersFollow
Scroll Up